Table 5.
Substrate | ETL | Perovskite | HTL | CE | Voc (mV) |
Jsc (mAcm−2) | FF (%) | ɳ (%) |
Ref. |
---|---|---|---|---|---|---|---|---|---|
FTO | TiO2 | MAPbI2Br | NiO | Au | 720 | 23.28 | 50.85 | 8.53 | [139] |
Cu2O | 1292 | 23.30 | 83.65 | 25.21 | |||||
CuI | 1138 | 23.33 | 72 | 21.80 | |||||
CuSCN | 950 | 23.30 | 59.91 | 13.35 | |||||
FTO | TiO2 treated with TiCl4 (no annealing) | CH3NH3PbI3 | Spiro-OMeTAD | Ag | 947 | 19.16 | 49.87 | 9.09 | [140] |
Annealed @ 150°C | 1016 | 21.57 | 64.65 | 14.16 | |||||
Annealed @ 300°C | 975 | 19.99 | 53.45 | 10.42 | |||||
Annealed @ 450°C | 990 | 20.49 | 58.91 | 11.98 | |||||
FTO | TiO2, PANI was incorporated at TiO2/MAPbI3 Interface |
MAPbI3 | Spiro-OMeTAD | Au | 960 | 17.95 | 62.1 | 10.7 | [141] |
PANI/MAPbI3 (65 nm) | 990 | 23.71 | 64.2 | 15.1 | |||||
PANI/MAPbI3 (100 nm) |
980 | 20.10 | 64.1 | 12.7 | |||||
PANI/MAPbI3 (135 nm) | 980 | 13.40 | 63.2 | 11.0 | |||||
PANI/MAPbI3 (170 nm) | 980 | 16.30 | 64.4 | 10.3 | |||||
ITO | C60 | Cs0.05 (FA0.98MA0.02)0.95Pb(I0.98Br0.02)3 (control) |
Poly (triaryl- amine) (PTAA) | Ag | 1130 | 25.25 | 80.45 | 23.0 | [142] |
Cs0.05 (FA0.98MA0.02)0.95Pb(I0.98Br0.02)3/FcTc2 (1.0 mg/mL) |
1184 | 25.68 | 82.32 | 25.0 | |||||
FTO | TiO2 | FA0.85MA0.15PbI3 (control) | Spiro-OMeTAD | Au | 1090 | 24.02 | 71.91 | 19.55 | [72] |
FA0.85MA0.15PbI3/TPFPB | 1120 | 24.69 | 78.22 | 21.60 | |||||
ITO | SnO2 | FAPbI3(control) | Spiro-OMeTAD | Au | 1136 | 26.27 | 78.49 | 23.42 | [143] |
FAPbI3/MS | 1164 | 26.31 | 82.82 | 25.38 | |||||
ITO | SnO2 | CsPbBrI2/BMIMBF4 (0 mg/mL) | Carbon | Carbon | 1140 | 14.33 | 69 | 11.37 | [137] |
CsPbBrI2/BMIMBF4 (0.25 mg/mL) | 1270 | 14.21 | 72 | 13.09 | |||||
CsPbBrI2/BMIMBF4 (0.50 mg/mL) | 1270 | 14.68 | 75 | 14.03 | |||||
CsPbBrI2/BMIMBF4 (1.0 mg/mL) | 1270 | 14.30 | 71 | 12.88 | |||||
CsPbBrI2/BMIMBF4 (2.5 mg/mL) | 1260 | 13.88 | 66 | 11.49 | |||||
CsPbBrI2/BMIMBF4 (5 mg/mL) | 1250 | 13.78 | 58 | 10.02 |